家禽用ワクチンの世界市場レポート 2025年

家禽用ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で28億1,000万米ドルに成長します。予測期間の成長は、疾病の変異と進化、養鶏産業の世界的拡大、タンパク質が豊富な食品への需要の増加、環境への懸念と持続可能性、動物福祉への注目の高まりに起因すると考えられます。予測期間における主な動向としては、ワクチン接種管理のデジタル化、抗生物質代替への注力、生産効率の高度化、新興感染症、環境問題などが挙げられます。

家禽ワクチン市場の成長は、人獣共通感染症の流行増加によって促進されると予想されます。人獣共通感染症は、ウイルス、細菌、寄生虫、真菌などの病原体によって引き起こされ、動物と人間の間で感染する病気です。土地利用の変化、都市化の進展、気候変動などの要因が人獣共通感染症の発症に関連し、トランスミッションのリスクを高めています。人獣共通感染症の急増は、家禽用ワクチンに対する需要の高まりにつながっています。例えば、世界保健機関（WHO）が2022年7月に発表した論文では、アフリカにおける人獣共通感染症患者が64％増加したと報告されています。人獣共通感染症の世界の増加とインドにおける増加は、効果的な予防対策の必要性を強調しており、ヒトにおける新興感染症が症例のかなりの部分を占めています。このようなリスクの増加は、家禽用ワクチンの需要を促進すると予想されます。

食肉の消費量の増加は、今後数年間の家禽用ワクチン市場の成長を促進すると予想されています。食肉は一般的に人間が食べる動物の肉を指し、多くの食生活において主要なタンパク質源として機能しています。家禽用ワクチンは、感染症から保護し、安全で高品質な食肉製品の生産を保証し、食中毒のリスクを最小限に抑え、生産性を向上させ、養鶏における抗生物質への依存を減らすために特別に設計されています。さらに、消費者は一般的な病気に対するワクチン接種を受けた家禽の肉を信頼し、好む傾向にあります。例えば、2023年10月、アイルランドの政府行政機関である中央統計局の報告によると、2022年、一人当たりの鶏肉消費量は3kg増加し（7%増）、合計41.9kgに達したが、他の食肉の消費量は減少しました。とはいえ、1人当たりの平均食肉総消費量は1kg近く増加し、93.9kgとなりました。全体的な食肉供給量は5万7,000トン増（4％増）の148万トンで、この増加には追加輸入が約3万3,000トン寄与しています。このように、食肉消費の増加が家禽用ワクチン市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界家禽用ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の家禽用ワクチン市場：成長率分析
• 世界の家禽用ワクチン市場の実績：規模と成長, 2019-2024
• 世界の家禽用ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界家禽用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の家禽用ワクチン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 豚ワクチン
• 家禽ワクチン
• 家畜ワクチン
• ペット用ワクチン
• 水産養殖ワクチン
• その他の動物用ワクチン
• 世界の家禽用ワクチン市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鳥インフルエンザ
• 感染性気管支炎
• 世界の家禽用ワクチン市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体ワクチン
• 凍結乾燥ワクチン
• ダクト
• 世界の家禽用ワクチン市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トキソイド
• 生弱毒化ワクチン
• 組み換えワクチン
• 不活化ワクチン
• 世界の家禽用ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブロイラー
• 層
• ブリーダー
• 世界の家禽用ワクチン市場、豚ワクチンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• 生弱毒化ワクチン
• DNAワクチン
• 組み換えワクチン
• トキソイドワクチン
• 世界の家禽用ワクチン市場、家禽ワクチンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生ワクチン
• 不活化ワクチン
• 組み換えワクチン
• サブユニットワクチン
• DNAワクチン
• 世界の家禽用ワクチン市場、家畜ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛ワクチン
• 豚ワクチン
• 羊ワクチン
• 世界の家禽用ワクチン市場、コンパニオンアニマルワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 犬のワクチン
• 猫のワクチン
• フェレットワクチン
• 世界の家禽用ワクチン市場養殖ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 魚ワクチン
• エビワクチン
• 世界の家禽用ワクチン市場、その他の動物用ワクチンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 野生動物ワクチン
• エキゾチック動物用ワクチン

第7章 地域別・国別分析

• 世界の家禽用ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の家禽用ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 家禽用ワクチン市場：競合情勢
• 家禽用ワクチン市場：企業プロファイル
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Ringpu Biology Overview, Products and Services, Strategy and Financial Analysis
  • MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Elanco Animal Health Incorporated
• Ceva Sante Animale S.A.
• Phibro Animal Health Corporation
• Huvepharma AD
• Venkys India Limited
• Vetoquinol S.A.
• Indian Immunologicals Limited
• Vaccination Services Pvt Ltd.
• Indovax Private Limited
• Bio-Vet Inc.
• Hester Biosciences Limited
• Intervet Inc.
• Anicon Labor GmbH
• CZ Veterinaria S.A.
• Bioproperties Pty Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 家禽用ワクチン市場2029：新たな機会を提供する国
• 家禽用ワクチン市場2029：新たな機会を提供するセグメント
• 家禽用ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Poultry vaccines, on the other hand, are immunizations administered to prevent and control diseases in poultry animals. These vaccinations play a crucial role in the poultry industry, particularly in chicken production, by aiming to enhance productivity through the prevention or limitation of clinical diseases at the farm level.

Poultry vaccines come in various types, including porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others. Porcine vaccines, a subset of poultry vaccines, involve the use of a high-pressure injector for immunizing pigs. This injector disperses 0.1 to 0.5 milliliters of the vaccination dosage. Porcine vaccines are applied to combat different diseases such as avian influenza and infectious bronchitis, requiring various dosage forms such as liquid vaccines, freeze-dried vaccines, and duct vaccines. Technologies involved in poultry vaccines encompass toxoid, live attenuated vaccines, recombinant vaccines, and inactivated vaccines, which are applied in broiler, layer, and breeder poultry.

The poultry vaccines market research report is one of a series of new reports from The Business Research Company that provides poultry vaccines market statistics, including poultry vaccines industry global market size, regional shares, competitors with a poultry vaccines market share, detailed poultry vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the poultry vaccines industry. This poultry vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The poultry vaccines market size has grown strongly in recent years. It will grow from $1.79 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to epidemic outbreaks, globalization of poultry trade, shifts in consumer demand, environmental concerns, emerging infectious diseases, focus on antibiotic alternatives.

The poultry vaccines market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to disease mutation and evolution, global expansion of poultry industry, increasing demand for protein-rich foods, environmental concerns and sustainability, rising focus on animal welfare. Major trends in the forecast period include digitalization in vaccination management, focus on antibiotic alternatives, advanced production efficiency, emerging infectious diseases, environmental concerns.

The growth in the poultry vaccine market is expected to be propelled by the increasing prevalence of zoonotic diseases. Zoonotic diseases, caused by pathogenic agents such as viruses, bacteria, parasites, and fungi, are diseases that can be transmitted between animals and humans. Factors such as changes in land use, heightened urbanization, and climate change have been linked to the onset of zoonotic diseases, increasing the risk of transmission. The surge in zoonotic cases has led to a growing demand for poultry vaccines. For instance, a July 2022 article published by the World Health Organization reported a 64% increase in zoonotic cases in Africa. The rise in zoonotic illnesses globally and in India underscores the need for effective prevention measures, with emerging infectious diseases in humans accounting for a significant portion of cases. This increased risk is expected to drive the demand for poultry vaccines.

The rising consumption of meat is anticipated to drive the growth of the poultry vaccines market in the coming years. Meat, which refers to the flesh of animals that humans typically eat, serves as a primary protein source in many diets. Poultry vaccines are specifically designed to protect against infectious diseases, ensuring the production of safe and high-quality meat products, minimizing the risk of foodborne illnesses, enhancing productivity, and reducing the reliance on antibiotics in poultry farming. Additionally, consumers tend to trust and prefer meat from poultry that has been vaccinated against common diseases. For example, in October 2023, the Central Statistics Office, a government administration in Ireland, reported that in 2022, per capita poultry meat consumption rose by 3 kg (+7%), reaching a total of 41.9 kg, while consumption of other meats declined. Nevertheless, the average total meat consumption per person increased by nearly 1 kg, amounting to 93.9 kg. Overall meat supply grew by 57,000 metric tons (+4%) to 1.48 million metric tons, with additional imports contributing around 33,000 metric tons to this increase. Thus, the rise in meat consumption is propelling the growth of the poultry vaccines market.

Technological advancements in poultry vaccines represent a significant trend gaining traction in the poultry vaccines market. The integration of innovative technologies has led to vaccines becoming highly effective and cost-efficient tools for preventing illnesses in poultry animals. Key players in the poultry vaccine market are actively engaged in the development of new technological solutions to enhance their market positions. For example, in October 2023, Zoetis Inc., a leading US-based animal health company, introduced Circomax, a porcine circovirus type 2 (PCV2) vaccine designed to address multiple genotypes (a, b). This vaccination aims to provide comprehensive protection against various PCV2 risks, including the three genotypes observed in the UK pig herd. Circomax is the only PCV2 vaccine licensed to safeguard against all three genotypes, demonstrating efficacy, convenience, and proven safety in protecting piglets from PCV2a, PCV2b, and PCV2d.

Major companies in the poultry vaccines market are forging strategic partnerships to foster product development and enhance their market positions. Collaborative efforts and partnerships in this sector promote innovation, leverage complementary expertise, and expedite the development and commercialization of advanced therapies. In October 2023, Kemin Industries Inc., a prominent US-based ingredient manufacturer dedicated to improving the quality of life for people and animals, joined forces with Ilender Corporation, a pharmaceutical company based in Peru, to launch the mefluvac H5 plus 8 vaccine. This vaccine aims to provide protection against avian influenza risks, specifically targeting the H5N1 and H5N8 subtypes. The vaccine, designed as an emulsified, trivalent, inactivated water-in-oil (W/O) virus for immunizing hens, offers a crucial defense against evolving threats by closely resembling local strains. The introduction of MEFLUVAC H5 PLUS 8 marks a significant milestone for Kemin Biologics' expansion in the Latin American market, contributing to the advancement of the Peruvian poultry sector by delivering robust, long-lasting protection for healthy birds.

In August 2022, Bimeda, an Ireland-based developer, manufacturer, and marketer of veterinary pharmaceuticals and animal care products, completed the acquisition of Afrivet for an undisclosed amount. This strategic move positions Bimeda as having the most extensive footprint among animal health companies in Africa. Afrivet, a South Africa-based manufacturer of poultry vaccines, contributes to Bimeda's commitment to serving the African continent's diverse animal health needs.

Major companies operating in the poultry vaccines market include Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Sante Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

North America was the largest region in the poultry vaccines market in 2024. The regions covered in the poultry vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the poultry vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The poultry vaccine market consists of revenues earned by entities by providing poultry vaccine services such as poultry health management, vaccination to poultry ducks, vaccination knowledge management, trainings. The market value includes the value of related goods sold by the service provider or included within the service offering. The poultry vaccine market also includes sales of chicken farm equipment, vaccination syringe, drugs, needle gun which are used in providing poultry vaccine services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Poultry Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on poultry vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for poultry vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The poultry vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Porcine Vaccines; Poultry Vaccine; Livestock Vaccine; Companion Animal Vaccine; Aquaculture Vaccines; Other Animal Vaccines
• 2) By Disease Type: Avain Influenza; Infectious Bronchitis
• 3) By Dosage Form: Liquid Vaccine; Freeze Dried Vaccine; Duct
• 4) By Technology: Toxoid; Live Attenuated Vaccines; Recombinant Vaccines; Inactivated Vaccines
• 5) By Application: Broiler; Layer; Breeder
• Subsegments:
• 1) By Porcine Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; DNA Vaccines; Recombinant Vaccines; Toxoid Vaccines
• 2) By Poultry Vaccines: Live Vaccines; Inactivated Vaccines; Recombinant Vaccines; Subunit Vaccines; DNA Vaccines
• 3) By Livestock Vaccines: Bovine Vaccines; Swine Vaccines; Ovine Vaccines
• 4) By Companion Animal Vaccines: Canine Vaccines; Feline Vaccines; Ferret Vaccines
• 5) By Aquaculture Vaccines: Fish Vaccines; Shrimp Vaccines
• 6) By Other Animal Vaccines: Wildlife Vaccines; Exotic Animal Vaccines
• Companies Mentioned: Merck & Co Inc.; Boehringer Ingelheim International GmbH; Zoetis Inc.; Ringpu Biology; MSD Animal Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Poultry Vaccines Market Characteristics

3. Poultry Vaccines Market Trends And Strategies

4. Poultry Vaccines Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Poultry Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Poultry Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Poultry Vaccines Market Growth Rate Analysis
• 5.4. Global Poultry Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Poultry Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Poultry Vaccines Total Addressable Market (TAM)

6. Poultry Vaccines Market Segmentation

• 6.1. Global Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Porcine Vaccines
• Poultry Vaccine
• Livestock Vaccine
• Companion Animal Vaccine
• Aquaculture Vaccines
• Other Animal Vaccines
• 6.2. Global Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Avian Influenza
• Infectious Bronchitis
• 6.3. Global Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Vaccine
• Freeze Dried Vaccine
• Duct
• 6.4. Global Poultry Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Toxoid
• Live Attenuated Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• 6.5. Global Poultry Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Broiler
• Layer
• Breeder
• 6.6. Global Poultry Vaccines Market, Sub-Segmentation Of Porcine Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• DNA Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• 6.7. Global Poultry Vaccines Market, Sub-Segmentation Of Poultry Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Vaccines
• Inactivated Vaccines
• Recombinant Vaccines
• Subunit Vaccines
• DNA Vaccines
• 6.8. Global Poultry Vaccines Market, Sub-Segmentation Of Livestock Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Vaccines
• Swine Vaccines
• Ovine Vaccines
• 6.9. Global Poultry Vaccines Market, Sub-Segmentation Of Companion Animal Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Vaccines
• Feline Vaccines
• Ferret Vaccines
• 6.10. Global Poultry Vaccines Market, Sub-Segmentation Of Aquaculture Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fish Vaccines
• Shrimp Vaccines
• 6.11. Global Poultry Vaccines Market, Sub-Segmentation Of Other Animal Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wildlife Vaccines
• Exotic Animal Vaccines

7. Poultry Vaccines Market Regional And Country Analysis

• 7.1. Global Poultry Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Poultry Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Poultry Vaccines Market

• 8.1. Asia-Pacific Poultry Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Poultry Vaccines Market

• 9.1. China Poultry Vaccines Market Overview
• 9.2. China Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Poultry Vaccines Market

• 10.1. India Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Poultry Vaccines Market

• 11.1. Japan Poultry Vaccines Market Overview
• 11.2. Japan Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Poultry Vaccines Market

• 12.1. Australia Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Poultry Vaccines Market

• 13.1. Indonesia Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Poultry Vaccines Market

• 14.1. South Korea Poultry Vaccines Market Overview
• 14.2. South Korea Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Poultry Vaccines Market

• 15.1. Western Europe Poultry Vaccines Market Overview
• 15.2. Western Europe Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Poultry Vaccines Market

• 16.1. UK Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Poultry Vaccines Market

• 17.1. Germany Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Poultry Vaccines Market

• 18.1. France Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Poultry Vaccines Market

• 19.1. Italy Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Poultry Vaccines Market

• 20.1. Spain Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Poultry Vaccines Market

• 21.1. Eastern Europe Poultry Vaccines Market Overview
• 21.2. Eastern Europe Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Poultry Vaccines Market

• 22.1. Russia Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Poultry Vaccines Market

• 23.1. North America Poultry Vaccines Market Overview
• 23.2. North America Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Poultry Vaccines Market

• 24.1. USA Poultry Vaccines Market Overview
• 24.2. USA Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Poultry Vaccines Market

• 25.1. Canada Poultry Vaccines Market Overview
• 25.2. Canada Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Poultry Vaccines Market

• 26.1. South America Poultry Vaccines Market Overview
• 26.2. South America Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Poultry Vaccines Market

• 27.1. Brazil Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Poultry Vaccines Market

• 28.1. Middle East Poultry Vaccines Market Overview
• 28.2. Middle East Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Poultry Vaccines Market

• 29.1. Africa Poultry Vaccines Market Overview
• 29.2. Africa Poultry Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Poultry Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Poultry Vaccines Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Poultry Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Poultry Vaccines Market Competitive Landscape
• 30.2. Poultry Vaccines Market Company Profiles
  • 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Ringpu Biology Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Poultry Vaccines Market Other Major And Innovative Companies

• 31.1. Elanco Animal Health Incorporated
• 31.2. Ceva Sante Animale S.A.
• 31.3. Phibro Animal Health Corporation
• 31.4. Huvepharma AD
• 31.5. Venkys India Limited
• 31.6. Vetoquinol S.A.
• 31.7. Indian Immunologicals Limited
• 31.8. Vaccination Services Pvt Ltd.
• 31.9. Indovax Private Limited
• 31.10. Bio-Vet Inc.
• 31.11. Hester Biosciences Limited
• 31.12. Intervet Inc.
• 31.13. Anicon Labor GmbH
• 31.14. CZ Veterinaria S.A.
• 31.15. Bioproperties Pty Ltd

32. Global Poultry Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Poultry Vaccines Market

34. Recent Developments In The Poultry Vaccines Market

35. Poultry Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Poultry Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Poultry Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Poultry Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer